Similar articles for PMID: 15705901

Year	Number of Results
1995	1
1998	2
1999	1
2002	1
2003	2
2004	4
2005	7
2006	10
2007	7
2008	4
2009	2
2010	6
2011	4
2012	3
2013	7
2014	4
2015	2
2016	2
2017	2
2020	1
2021	1
2022	2
2024	0

1

Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.

Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G, Kloog Y. Blum R, et al. Cancer Res. 2005 Feb 1;65(3):999-1006. Cancer Res. 2005. PMID: 15705901

2

Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).

Blum R, Elkon R, Yaari S, Zundelevich A, Jacob-Hirsch J, Rechavi G, Shamir R, Kloog Y. Blum R, et al. Cancer Res. 2007 Apr 1;67(7):3320-8. doi: 10.1158/0008-5472.CAN-06-4287. Cancer Res. 2007. PMID: 17409441

3

The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.

Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y. Barkan B, et al. Clin Cancer Res. 2006 Sep 15;12(18):5533-42. doi: 10.1158/1078-0432.CCR-06-0792. Clin Cancer Res. 2006. PMID: 17000690

4

A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.

Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S. Das B, et al. Cancer Res. 2005 Aug 15;65(16):7267-75. doi: 10.1158/0008-5472.CAN-04-4575. Cancer Res. 2005. PMID: 16103078

5

E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition.

Blum R, Nakdimon I, Goldberg L, Elkon R, Shamir R, Rechavi G, Kloog Y. Blum R, et al. Int J Cancer. 2006 Aug 1;119(3):527-38. doi: 10.1002/ijc.21735. Int J Cancer. 2006. PMID: 16496386 Free article.

6

Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.

Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y. Yaari S, et al. Clin Cancer Res. 2005 Jun 15;11(12):4321-30. doi: 10.1158/1078-0432.CCR-04-2071. Clin Cancer Res. 2005. PMID: 15958613

7

Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells.

Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Borea PA. Merighi S, et al. Biochem Pharmacol. 2006 Jun 28;72(1):19-31. doi: 10.1016/j.bcp.2006.03.020. Epub 2006 Mar 29. Biochem Pharmacol. 2006. PMID: 16682012

8

[Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].

Wu Q, Yang SH, Wang RY, Ye SN, Xia T, Ma DZ. Wu Q, et al. Ai Zheng. 2005 May;24(5):531-5. Ai Zheng. 2005. PMID: 15890092 Chinese.

9

Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway.

Jin HO, An S, Lee HC, Woo SH, Seo SK, Choe TB, Yoo DH, Lee SB, Um HD, Lee SJ, Park MJ, Kim JI, Hong SI, Rhee CH, Park IC. Jin HO, et al. Cell Signal. 2007 Jul;19(7):1393-403. doi: 10.1016/j.cellsig.2006.12.014. Epub 2007 Jan 20. Cell Signal. 2007. PMID: 17307335

10

Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.

da Silva Morais A, Saliez A, Leclercq I, Horsmans Y, Stärkel P. da Silva Morais A, et al. Clin Sci (Lond). 2008 Jan;114(1):73-83. doi: 10.1042/CS20070152. Clin Sci (Lond). 2008. PMID: 17678500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year